Asthma is the most common chronic illness among children, and inhaled corticosteroids
(ICS) are the most effective long‐term therapy available for suppressing airway inflammation …

Inhaled corticosteroids reduce asthma symptoms and exacerbations, improve lung function,
and reduce airway inflammation and bronchial hyperreactivity more effectively than other …

Asthma is a chronic inflammatory disease characterized by symptoms of cough, dyspnea,
chest tightness, and wheeze. Inhaled corticosteroids (ICS) have been recommended as …

Abstract Background Inhaled corticosteroids (ICSs) are the mainstay of daily controller
treatment for persistent and uncontrolled asthma. However, many clinicians are wary of ICSs …

Asthma is a leading cause of morbidity in children, leading to frequent emergency room
visits and hospitalizations. In recent years, a steady increase in the number of cases of …

Inhaled corticosteroids (ICS) are an established treatment for asthma in childhood. Recent
data bring to light growing concerns that ICS may have significant effects on growth velocity …

Different wheezing syndromes can carry the diagnostic label of “asthma,” especially in very
young children, and an accurate differential diagnosis is essential for improving outcomes …

Asthma is a chronic respiratory disease affecting approximately 300 million people
worldwide. 1 In the United States, an estimated 43.3 million people, including 9.3 million …

Inhaled glucocorticoids are the preferred long-term controller for initiating treatment of
persistent asthma. Early intervention with inhaled glucocorticoids achieves symptom control …

Inhaled corticosteroids (ICS) are the most effective anti-inflammatory drugs for the treatment
of persistent asthma in children. Treatment with ICS decreases asthma mortality and …